Skip to main content
. 2013 Oct 11;8(10):e76455. doi: 10.1371/journal.pone.0076455

Figure 2. Evaluation of MRD and relapse in paediatric ALL patients.

Figure 2

The proportion of patients with low MRD (<10−4), moderate (≥10−4, <10−3), high (≥10−3<10−2) and very high MRD (≥10−2) at day 15 and day 33 by relapse status for A) precursor B and B) T-ALL patients.